http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Lee, Hyukmin,Yoon, Eun-Jeong,Kim, Dokyun,Jeong, Seok Hoon,Shin, Jong Hee,Shin, Jeong Hwan,Shin, Kyeong Seob,Kim, Young Ah,Uh, Young,Park, Chan,Lee, Kwang Jun European Centre for Disease Prevention and Control 2018 Euro surveillance : bulletin européen sur l Vol.23 No.42
<P>Surveillance plays a pivotal role in overcoming antimicrobial resistance (AMR) in bacterial pathogens, and a variety of surveillance systems have been set up and employed in many countries. In 2015, the World Health Organization launched the Global Antimicrobial Resistance Surveillance System (GLASS) as a part of the global action plan to enhance national and global surveillance and research. The aims of GLASS are to foster development of national surveillance systems and to enable collection, analysis and sharing of standardised, comparable and validated data on AMR between different countries. The South Korean AMR surveillance system, Kor-GLASS, is compatible with the GLASS platform and was established in 2016 and based on the principles of representativeness, specialisation, harmonisation and localisation. In this report, we summarise principles and processes in order to share our experiences with other countries planning to establish a national AMR surveillance system. The pilot operation of Kor-GLASS allowed us to understand the national burden of specific infectious diseases and the status of bacterial AMR. Issues pertaining to high costs and labour-intensive operation were raised during the pilot, and improvements are being made.</P>
Lee, Hyukmin,Yoon, Eun-Jeong,Kim, Dokyun,Jeong, Seok Hoon,Won, Eun Jeong,Shin, Jong Hee,Kim, Si Hyun,Shin, Jeong Hwan,Shin, Kyeong Seob,Kim, Young Ah,Uh, Young,Yang, Ji Woo,Kim, Il Hwan,Park, Chan,Lee European Centre for Disease Prevention and Control 2018 Euro surveillance : bulletin européen sur l Vol.23 No.42
<P>The Korean government established an antimicrobial resistance (AMR) surveillance system, compatible with the Global AMR Surveillance System (GLASS): Kor-GLASS. We describe results from the first year of operation of the Kor-GLASS from May 2016 to April 2017, comprising all non-duplicated clinical isolates of major pathogens from blood<I>,</I> urine<I>,</I> faeces and urethral and cervical swabs from six sentinel hospitals. Antimicrobial susceptibility tests were carried out by disk diffusion, Etest, broth microdilution and agar dilution methods. Among 67,803 blood cultures, 3,523 target pathogens were recovered. The predominant bacterial species were <I>Escherichia coli</I> (n = 1,536), <I>Klebsiella pneumoniae</I> (n = 597) and <I>Staphylococcus aureus</I> (n = 584). From 57,477 urine cultures, 6,394 <I>E. coli</I> and 1,097 <I>K. pneumoniae</I> were recovered. Bloodstream infections in inpatients per 10,000 patient-days (10TPD) were highest for cefotaxime-resistant <I>E. coli</I> with 2.1, followed by 1.6 for meticillin-resistant <I>Sta. aureus</I>, 1.1 for imipenem-resistant <I>Acinetobacter baumannii</I>, 0.8 for cefotaxime-resistant <I>K. pneumoniae</I> and 0.4 for vancomycin-resistant <I>Enterococcus faecium</I>. Urinary tract infections in inpatients were 7.7 and 2.1 per 10TPD for cefotaxime-resistant <I>E. coli</I> and <I>K. pneumoniae</I>, respectively. Kor-GLASS generated well-curated surveillance data devoid of collection bias or isolate duplication. A bacterial bank and a database for the collections are under development.</P>